Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

InflaRx (IFRX) EBT Margin (2022 - 2025)

Historic EBT Margin for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to 9025.59%.

  • InflaRx's EBT Margin rose 27550500.0% to 9025.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 23842.19%, marking a year-over-year increase of 72766200.0%. This contributed to the annual value of 27781.81% for FY2024, which is 398488800.0% up from last year.
  • Latest data reveals that InflaRx reported EBT Margin of 9025.59% as of Q3 2025, which was up 27550500.0% from 31427.3% recorded in Q2 2025.
  • In the past 5 years, InflaRx's EBT Margin ranged from a high of 2147601.65% in Q4 2024 and a low of 534301.36% during Q4 2023
  • For the 4-year period, InflaRx's EBT Margin averaged around 80491.28%, with its median value being 9025.59% (2025).
  • As far as peak fluctuations go, InflaRx's EBT Margin tumbled by 2000000000bps in 2023, and later skyrocketed by 2000000000bps in 2024.
  • Over the past 4 years, InflaRx's EBT Margin (Quarter) stood at 200.3% in 2022, then crashed by -266646bps to 534301.36% in 2023, then skyrocketed by 502bps to 2147601.65% in 2024, then tumbled by -100bps to 9025.59% in 2025.
  • Its last three reported values are 9025.59% in Q3 2025, 31427.3% for Q2 2025, and 34706.8% during Q1 2025.